ReproNovo
PrivateLast Round
Series A
May 21, 2025
Total Funding Raised
$65M
Company Overview
ReproNovo is a biopharmaceutical company that develops innovative treatments for reproductive medicine and women's health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReproNovo Comparables
Compare ReproNovo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivalyx | 84% | |
| Bridge to Life | 84% | |
| Organ Recovery Systems | 79% |
ReproNovo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 21, 2025 |
Key People
Founding team and executive leadership
ReproNovo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ALSA Ventures | Series A |
| M Ventures | Series A, Seed |
| Ysios Capital | Series A |
| AXA IM Alts | Series A |
| BNP Paribas Asset Management | Series A |
| Jeito Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 291% MoM, reaching 1.6K.
- May 21, 2025
$65M Series A round completed.
ReproNovo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ReproNovo's valuation, stock price, and market status.
Is ReproNovo a public or private company?
ReproNovo is a private company.
What is the current stock price of ReproNovo?
ReproNovo is a private company with no public stock price. No recent secondary market data is available.
How much is ReproNovo worth (valuation)?
Valuation information for ReproNovo is not publicly available.
Can I buy ReproNovo stock?
ReproNovo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ReproNovo's last funding round?
ReproNovo's most recent funding round was Series A on May 21, 2025.
Who are the main investors in ReproNovo?
Key investors in ReproNovo include Jeito.
Will ReproNovo IPO soon?
No public IPO plans have been announced for ReproNovo.
How can I track ReproNovo secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ReproNovo's secondary market activity and sign up for updates.